Skip to main content
. 2021 Dec 8;19:95. doi: 10.18332/tid/143282

Table 1.

Participants’ characteristics by interventions and age groups

Characteristics Age <21 years (n=2117) Age ≥21 years (n=852)
BTI+AG (n=1034) n (%) AG (n=566) n (%) CTA (n=517) n (%) BTI+AG (n=404) n (%) AG (n=205) n (%) CTA (n=243) n (%)
Age (years)* 18.8 (18;19;19) 18.8 (18;19;19) 18.8 (18;19;19) 23.4 (21;22;24) 23.6 (21;23;24) 23.4 (21;22;25)
Male 728 (70.4) 369 (65.2) 385 (74.5) 271 (67.1) 149 (72.7) 173 (71.2)
Race
Black 202 (19.5) 110 (19.4) 94 (18.2) 87 (21.5) 30 (14.6) 58 (23.9)
White 652 (63.1) 348 (61.5) 339 (65.6) 237 (58.7) 126 (61.5) 133 (54.7)
Multi-race 106 (10.3) 64 (11.3) 53 (10.3) 40 (9.9) 22 (10.7) 24 (9.9)
Other 74 (7.2) 44 (7.8) 31 (6.0) 40 (9.9) 27 (13.2) 28 (11.5)
Hispanic 220 (21.3) 106 (18.7) 103 (19.9) 94 (23.3) 50 (24.4) 57 (23.5)
Married 49 (4.7) 23 (4.1) 21 (4.1) 92 (22.8) 41 (20.0) 45 (18.5)
Education level
High school diploma/GED 795 (76.9) 418 (73.9) 407 (78.7) 107 (26.5) 71 (34.6) 75 (30.9)
Vocational training 11 (1.1) 1 (0.2) 1 (0.2) 0 (0.0) 6 (2.9) 3 (1.25)
Some college/associate’s 226 (21.9) 134 (23.7) 105 (20.3) 219 (54.2) 101 (49.3) 121 (49.8)
Bachelor’s degree or higher 2 (0.2) 13 (2.3) 4 (0.8) 78 (19.3) 27 (13.2) 44 (18.1)
Military rank
Active duty 940 (91.3) 503 (89.8) 456 (88.4) 322 (80.1) 167 (82.7) 189 (78.8)
Guard 67 (6.5) 43 (7.7) 44 (9.5) 54 (13.4) 23 (11.4) 28 (11.7)
Reserve 23 (2.2) 14 (2.5) 11 (2.1) 26 (20.5) 12 (5.9) 23 (9.6)
Prior tobacco use
Regular mono use 136 (13.2) 69 (12.2) 60 (11.6) 39 (9.7) 29 (14.2) 32 (13.2)
Regular dual/poly use 121 (11.7) 69 (12.2) 73 (14.2) 41 (10.2) 15 (7.4) 24 (9.9)
Seldom use 102 (9.9) 59 (10.4) 43 (8.3) 50 (12.4) 17 (8.3) 24 (9.9)
Non-use 673 (65.2) 368 (65.1) 340 (65.9) 274 (67.8) 143 (70.1) 163 (67.1)
Prior ENDS use
Regular ENDS mono use 69 (7.0) 36 (6.4) 27 (5.2) 10 (2.5) 8 (3.9) 8 (3.3)
Regular concurrent use of ENDS and other products 75 (7.3) 50 (8.9) 56 (10.9) 23 (5.7) 7 (3.4) 15 (6.2)
Regular other products use 113 (11.0) 52 (9.2) 50 (9.7) 47 (11.6) 29 (14.2) 33 (13.6)
Seldom use 102 (9.9) 59 (10.4) 43 (8.3) 50 (12.4) 17 (8.3) 24 (9.9)
Non-use 673 (65.2) 368 (65.1) 340 (65.9) 274 (67.8) 143 (70.1) 163 (67.1)
Tobacco use at 3 months
Regular mono use 80 (8.6) 43 (8.9) 41 (9.0) 28 (7.9) 9 (5.1) 12 (5.6)
Regular dual/poly use 78 (8.4) 34 (7.0) 43 (9.5) 16 (4.5) 7 (4.0) 12 (5.6)
Seldom use 58 (6.3) 30 (6.2) 23 (5.1) 27 (7.6) 12 (6.9) 15 (7.0)
Non-use 711 (76.7) 377 (77.9) 348 (76.5) 285 (80.1) 147 (84.0) 175 (81.8)
ENDS use at 3 months
Regular ENDS mono use 49 (5.3) 26 (5.4) 21 (4.6) 11 (3.1) 4 (2.3) 3 (1.4)
Regular concurrent use of ENDS and other products 59 (6.4) 24 (5.0) 27 (5.9) 7 (2.0) 5 (2.3) 9 (4.2)
Regular other products use 50 (5.4) 27 (5.6) 36 (7.9) 26 (7.3) 7 (4.0) 12 (5.6)
Seldom use 58 (6.3) 30 (6.2) 23 (5.1) 27 (7.6) 12 (6.9) 15 (7.0)
Non-use 711 (76.7) 377 (77.9) 348 (76.5) 285 (80.1) 147 (84.0) 175 (81.8)
*

Mean (1st quartile; median; 3rd quartile). BTI: brief tobacco intervention. CTA: national cancer institute’s clearing the air intervention. AG: airman’s guide intervention. GED: general educational development.